Company profile for OnQuality Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

OnQuality is a privately-held, start-up pharmaceutical company, that is dedicated to and pioneering the drug development toward solving multiple unmet clinical needs, which would improve both the quality-of-life and the treatment outcome of cancer patients. Our leading compound is in the area of Oncodermatology, which is being studied in a phase 2 clinical trial. We also have two assets in pre-clinical stage scheduled to file ...
OnQuality is a privately-held, start-up pharmaceutical company, that is dedicated to and pioneering the drug development toward solving multiple unmet clinical needs, which would improve both the quality-of-life and the treatment outcome of cancer patients. Our leading compound is in the area of Oncodermatology, which is being studied in a phase 2 clinical trial. We also have two assets in pre-clinical stage scheduled to file INDs in 2019 and two others in early discovery stage.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
1588 Lianhang road Building 4 Shanghai,
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/onquality-announces-fda-clearance-of-ind-application-for-oql025-for-the-treatment-of-egfr-inhibitor-induced-acneiform-rash-302025647.html

PR NEWSWIRE
04 Jan 2024

https://www.prnewswire.com/news-releases/onquality-announces-fda-clearance-of-ind-application-for-oql051-for-the-prophylaxis-of-chemotherapy-induced-diarrhea-301844368.html

PR NEWSWIRE
06 Jun 2023

https://www.prnewswire.com/news-releases/onquality-announces-fda-clearance-of-ind-application-for-oql036-for-the-prophylaxis-of-capecitabine-induced-hand-foot-syndrome-301811098.html

PR NEWSWIRE
28 Apr 2023

https://www.prnewswire.com/news-releases/onquality-pharmaceuticals-presented-preclinical-data-for-oql025-and-oql06x-novel-therapeutics-for-egfr-inhibitor-induced-acneiform-rash-and-diarrhea-at-the-aacr-annual-meeting-301799697.html

PR NEWSWIRE
18 Apr 2023

https://www.prnewswire.com/news-releases/onquality-pharmaceuticals-announces-presentations-of-oql025-and-oql06x-at-the-aacr-annual-meeting-301772559.html

PR NEWSWIRE
15 Mar 2023

https://www.prnewswire.com/news-releases/onquality-pharmaceuticals-expands-part-2-of-the-nova-ii-phase-2-clinical-trial-to-china-and-india-301713733.html

PR NEWSWIRE
05 Jan 2023

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty